Every time a patient has blood drawn, a biopsy collected, or a tissue sample prepared for analysis, a chain of events begins that most people never see. Specimens travel from collection point to processing bench to pathologist’s desk, generating data at every step along the way. Keeping that chain intact, accurate, and fast is not a logistical afterthought. It is the operational foundation on which laboratory medicine runs.
The technology that holds that foundation together is called a laboratory information system, commonly referred to as an LIS. For lab directors, pathologists, technicians, and healthcare administrators, it is the central nervous system of the entire operation.
Table of Contents
Defining the Laboratory Information System
A laboratory information system is a software platform designed to manage the end-to-end workflow of a diagnostic laboratory. It tracks specimens from the moment they are received, routes them through the appropriate processing steps, captures results, and delivers reports to the clinicians and patients who need them. In doing so, it maintains a continuous, auditable record of everything that happens to a sample and the data it produces.
At its most fundamental level, the LIS performs four core functions. It manages patient and specimen data, ensuring that every sample is correctly identified and associated with the right person, order, and test. It coordinates workflow, assigning cases to the appropriate personnel and equipment and flagging anything that falls outside expected parameters. It integrates with laboratory instruments, capturing results electronically rather than relying on manual transcription. And it generates reports, distributing results to ordering physicians, electronic health records, and billing systems in formats that meet clinical and regulatory requirements.
In practice, modern LIS platforms do considerably more than this baseline. They track turnaround times, identify bottlenecks, automate reflex testing rules, support quality assurance protocols, manage billing codes, and increasingly serve as the integration hub between the laboratory and a broader ecosystem of digital tools including digital pathology viewers, AI analytics platforms, and revenue cycle management systems.
LIS Versus LIMS: Understanding the Distinction
The terms laboratory information system and laboratory information management system are sometimes used interchangeably, but they refer to meaningfully different things. Understanding the distinction matters when evaluating software for a specific lab environment.
A laboratory information management system, or LIMS, was originally developed for research and industrial laboratory environments. It excels at sample tracking, inventory management, and experiment documentation across scientific disciplines such as environmental testing, pharmaceutical manufacturing, food safety, and biotech research. LIMS platforms are highly configurable and data-centric, designed for contexts where the primary concern is managing samples and scientific datasets across complex experimental workflows.
A laboratory information system, by contrast, was developed specifically for clinical and diagnostic medicine. It is built around patient care workflows, regulatory requirements specific to healthcare settings, and the direct integration of diagnostic results into clinical decision-making. An LIS manages physician orders, patient identities, HIPAA compliance, clinical reporting, and billing in ways that a general-purpose LIMS is not designed to handle.
For anatomic pathology labs, molecular diagnostics labs, and other clinical settings, an LIS is the appropriate foundation. Labs that attempt to adapt a LIMS platform to clinical diagnostic work often find themselves compensating for gaps that a purpose-built LIS would not create in the first place.
How a Laboratory Information System Works in Practice
Understanding the LIS is easier when traced through a real workflow. Consider a surgical pathology case, beginning with a tissue specimen collected during a procedure.
When the specimen arrives at the lab, it is accessioned into the LIS. A unique identifier is assigned and linked to the patient record, the ordering physician, and the test being requested. Labels are printed, often automatically, and the specimen moves into processing. As it passes through grossing, embedding, sectioning, staining, and any additional ancillary testing, the LIS tracks its status at each stage.
When the pathologist is ready to review the case, the LIS surfaces the relevant prior history, any outstanding ancillary results, and in modern platforms with digital pathology integration, the digital slide images themselves. The pathologist renders a diagnosis, the LIS captures it, and the final report is generated and distributed to the ordering clinician and the patient’s medical record. Simultaneously, billing codes are attached and transmitted to the revenue cycle management system.
Throughout this process, the LIS is monitoring for exceptions. If a turnaround time threshold is approaching, it flags the case. If a quality assurance rule is triggered, it routes the case for secondary review. If a reflex test is indicated based on the diagnosis entered, it initiates the order automatically. All of this happens within a single system, without manual intervention at each handoff point.
The result is a faster, more consistent, and more auditable workflow than anything a paper-based or fragmented digital system can produce.
Why the LIS Has Become a Strategic Asset
For much of its history, the laboratory information system was viewed as operational infrastructure, important but unglamorous, the software that kept the lights on in the lab. That perception has changed substantially as laboratory medicine has moved to the center of clinical decision-making and as digital pathology and artificial intelligence have introduced new capabilities and new complexity.
Labs that can handle more cases without proportional increases in staffing, that can support remote pathologist workflows, that can integrate AI-powered image analysis directly into the diagnostic workflow, and that can document digital pathology utilization for reimbursement purposes are operating at a structural advantage over those that cannot. The LIS is the platform that either enables or constrains all of those capabilities.
This shift has elevated the LIS selection decision from a purchasing question to a strategic one. Choosing the wrong platform does not just create operational friction. It can cap a lab’s ability to grow, limit its access to new technologies, and leave it exposed to competitive pressure from labs that have made better infrastructure investments.
The Role of the LIS in Digital Pathology
Digital pathology has made the capabilities of the underlying LIS more consequential than ever. When labs adopt whole slide imaging and begin reviewing cases from digital slides rather than glass, the LIS either becomes a unified hub that brings imaging and case data together, or it becomes another disconnected system that pathologists have to navigate around.
The distinction matters because fragmented digital pathology architectures, where the viewer exists separately from the LIS, create workflow friction at exactly the point where consistency matters most. Pathologists move between systems to complete routine tasks. Context must be manually reconstructed. Scaling becomes difficult, and introducing AI tools later requires significant re-architecture.
Modern digital pathology LIS software integrates directly with whole slide imaging viewers, surfacing digital slides in context alongside case records, prior history, and reporting tools. This allows pathologists to complete their entire workflow in a single environment, improving both efficiency and diagnostic consistency.
As AI tools become operational realities in pathology labs rather than pilot projects, the LIS also determines how readily those tools can be incorporated. Labs whose LIS infrastructure is AI-ready, meaning it can receive and contextualize AI-generated findings alongside traditional case data, are better positioned to take advantage of these capabilities as they mature.
Top Providers of Laboratory Information Systems
The LIS market includes a range of vendors with different areas of specialty, deployment models, and target lab environments. The right platform for any given lab depends on its size, specialty mix, existing technology infrastructure, and strategic priorities. The following providers represent some of the most widely evaluated options in the current market.
NovoPath
NovoPath offers NovoPath 360, a true software-as-a-service LIS purpose-built for anatomic pathology, molecular diagnostics, and veterinary pathology laboratories. The platform is delivered via Microsoft’s cloud infrastructure and is SOC 2 Type II certified, with a design philosophy centered on workflow-first digital pathology integration. NovoPath 360 allows pathologists to review digital slides within the LIS itself, synchronizing imaging, reporting, and case management in real time. The platform integrates with more than 150 electronic medical record systems and supports voice dictation, automated case assignment, and customizable reporting. With over 30 years of anatomic pathology experience, NovoPath brings deep domain knowledge to implementation and support alongside its technology.
Clinisys
Clinisys is a large enterprise that has consolidated several well-established laboratory software brands, including Sunquest and PowerPath. Its breadth of offerings and established presence in hospital and health system environments make it a common shortlist entry for organizations seeking a vendor with scale and long-term stability. Clinisys supports a wide range of laboratory disciplines and is actively working to modernize its platform portfolio while maintaining support for its installed base of legacy customers.
Epic Beaker
For health systems already standardized on the Epic electronic health record, Beaker offers a tightly integrated LIS that operates within the broader Epic ecosystem. Its primary advantage is seamless alignment with the EMR, which reduces interoperability complexity for organizations where Epic is the clinical platform of record. Epic Beaker supports both clinical pathology and anatomic pathology workflows and benefits from Epic’s wide deployment across major health systems in the United States.
Oracle Health CoPathPlus
CoPathPlus is a widely deployed anatomic pathology system that became part of Oracle Health through Oracle’s acquisition of Cerner. It remains a significant presence in hospital-based pathology environments, particularly among organizations that have standardized on Cerner solutions more broadly. Oracle’s current focus is on integrating Cerner assets into its larger enterprise health platform, with an emphasis on interoperability and data infrastructure.
LigoLab
LigoLab positions itself as a unified LIS and revenue cycle management platform, meaning its laboratory operations and billing modules are built on a single integrated architecture rather than connected through integrations. This approach appeals to pathology groups that want to reduce the friction between clinical operations and billing workflow. LigoLab is used by multi-facility pathology groups processing high case volumes and supports clinical, anatomic pathology, and molecular diagnostic disciplines within a single platform.
XIFIN
XIFIN offers a configurable SaaS LIS with a notable strength in interoperability, making it an option for labs that want LIS flexibility within a broader technology platform. It has a meaningful presence in anatomic pathology and molecular diagnostics and is frequently evaluated alongside more specialized LIS vendors by labs that prioritize billing integration and cross-platform data flow.
Orchard Software
Orchard Software is a long-standing LIS provider that remains a considered option for laboratories moving beyond physician office scale and seeking outreach or pathology modules. It has a reputation for reliability and strong customer support, though some users note that the platform can carry a learning curve as labs scale and workflows become more complex.
Choosing the Right Laboratory Information System
Selecting an LIS is one of the most consequential infrastructure decisions a laboratory will make. The right choice depends on a careful evaluation of several factors specific to each lab’s environment.
- Specialty fit: A platform built specifically for anatomic pathology will serve a surgical pathology lab better than a general-purpose clinical LIS. Labs should confirm that any system under evaluation has genuine depth in their primary disciplines, not just a checkbox list of supported specialty modules
- Digital pathology readiness: Labs that are investing in whole slide imaging or planning to do so should evaluate how each LIS handles digital slide integration. A viewer-first architecture that treats imaging as an add-on will create friction that compounds over time
- AI compatibility: As AI diagnostic tools mature, the LIS will need to receive, contextualize, and act on AI-generated findings. Labs should evaluate whether potential platforms are architecturally ready to support this kind of integration
- Deployment model: Cloud-based SaaS platforms offer advantages in scalability, uptime, and maintenance overhead relative to on-premise installations, but each lab should assess its IT infrastructure, security requirements, and long-term cost structure before deciding
- Integration ecosystem: Most labs operate within a broader technology environment that includes EMRs, billing systems, instruments, and specialty applications. The LIS needs to connect cleanly with that ecosystem, and the integration track record of any vendor under evaluation deserves careful scrutiny
- Implementation support: A technically capable platform paired with an inexperienced implementation team can produce a poor outcome. Labs should evaluate not just the software but the vendor’s depth of domain expertise in the lab environments they serve
The LIS as a Foundation for the Future of Laboratory Medicine
The laboratory information system has always been essential infrastructure. What has changed is the scope of what it must support and the strategic weight of the decisions that flow from it.
In a diagnostic environment shaped by digital pathology, artificial intelligence, remote workflows, and rising case volumes, the LIS is no longer just a data management tool. It is the operational hub through which a lab’s capabilities, its capacity, its diagnostic accuracy, and its competitive positioning are either realized or constrained.
Labs that approach their LIS selection with the same rigor they bring to clinical and scientific decisions will be better positioned to meet the demands of a field that is changing faster than at any point in its history.